Total Reports
21
FDA CVM filings
Dog /
FDA CVM · 2025 release 21 reports on file
Spitz - Japanese - FDA Adverse Event Profile
Adverse-event records for Spitz - Japanese (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Among dog breeds, Spitz - Japanese is #353 by FDA report volume; 19.0% of its 21 reports (4) were death-coded.
- #353
- most-reported dog breed
- 19.0%
- death-coded report share
- 5
- Emesis - top reaction
- 8.5 yr
- average age at report
Report counts track breed popularity and reporting activity, not real-world risk, read this alongside how common the breed is.
Deaths Reported
4
of 21 reports
Death Rate
19.0%
death-coded share
Avg Age at Report
8.5 yr
9.3 kg avg weight
Death-Coded Outcome Share
Spitz - Japanese death-coded reports 19.0%
Cross-breed median
19.0% of 21 spitz - japanese reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 9.3 kg (20.5 lbs)
Top Reported Reactions
Emesis 5
Vomiting 5
Seizure NOS 3
Not eating 3
Diarrhoea 2
Most Referenced Drugs
Milbemycin Oxime + Spinosad 8
Milbemycin Oxime 2
Fluralaner Chew Tablets 2
Cetirizine 1
Spinosad 1
Outcome Breakdown
Recovered/Normal
8 (38.1%)
Outcome Unknown
6 (28.6%)
Euthanized
3 (14.3%)
Ongoing
3 (14.3%)
Died
1 (4.8%)
Gender Distribution
Male 13 (61.9%)
Female 8 (38.1%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2011 | 1 | |
| 2012 | 2 | |
| 2013 | 1 | |
| 2014 | 3 | |
| 2015 | 3 | |
| 2016 | 2 | |
| 2017 | 1 | |
| 2018 | 3 | |
| 2019 | 1 | |
| 2020 | 2 | |
| 2022 | 1 | |
| 2023 | 1 | |
Spitz - Japanese Pet Health Insights
Spitz - Japanese accounts for 21 FDA adverse event reports, ranking #353 by volume among dog breeds, with 4 reports (19.0%) coded as a death outcome. Mean age at report: 8.5 years, average weight 9.3 kg (20.5 lbs).
Top reported signs: Emesis (5), Vomiting (5), Seizure NOS (3). Most-referenced drug: Milbemycin Oxime + Spinosad (8 reports), followed by Milbemycin Oxime (2) and Fluralaner Chew Tablets (2).
Outcome coding on 21 status-recorded reports is dominated by Recovered/Normal (38.1%). Annual submissions ranged 2,011-2,023 across 12 years on file.
Dog Breeds With a Similar Report Volume
Terrier - Bull - Miniature
21 reports · 19.0% death rate
Otterhound
22 reports · 9.1% death rate
Sheepdog - Iceland
22 reports · 4.5% death rate
Shepherd Dog - Belgian Groenendael
20 reports · 5.0% death rate
Shepherd Dog - Caucasian
20 reports · 0.0% death rate
Spitz - Finnish
22 reports · 13.6% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Spitz - Japanese? ▼
There are 21 adverse event reports involving Spitz - Japanese in the FDA database, with 4 reports involving death (19.0% death rate). Spitz - Japanese ranks #353 by report volume.
What are the most common adverse reactions reported for Spitz - Japanese? ▼
The most commonly reported adverse reactions for Spitz - Japanese are Emesis (5 reports), Vomiting (5 reports), Seizure NOS (3 reports), Not eating (3 reports), Diarrhoea (2 reports).
What drugs are most frequently associated with Spitz - Japanese adverse events? ▼
The drugs most frequently referenced in Spitz - Japanese adverse event reports are Milbemycin Oxime + Spinosad (8 reports), Milbemycin Oxime (2 reports), Fluralaner Chew Tablets (2 reports), Cetirizine (1 reports), Spinosad (1 reports).
What is the average age of Spitz - Japanese in adverse event reports? ▼
The average age of Spitz - Japanese at the time of adverse event reports is 8.5 years, with an average weight of 9.3 kg (20.5 lbs).
Does a high number of adverse event reports mean Spitz - Japanese is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Spitz - Japanese safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.